Acquirer
Dechra Pharmaceuticals
Dechra Pharmaceuticals appears as the named buyer in 4 recorded transactions between 2016 and 2024, most often in healthcare & life sciences. 2 of those were bought from a private equity seller, which makes this a buyer that funds in the sector actually exit to.
Record
What Dechra Pharmaceuticals has bought
Every recorded transaction where Dechra Pharmaceuticals is the named buyer. Most private deals never disclose a consideration, so a dash is the normal case rather than a gap in the record.
| Target | Sector | Sold by | Date | Consideration |
|---|---|---|---|---|
| Invetx | Healthcare & Life Sciences | Eight Roads PE | 2024-07-18 | $520m |
| Apex Laboratories Pty Ltd. | Healthcare & Life Sciences | — | 2016-09-16 | $39m |
| Putney | Healthcare & Life Sciences | NewSpring Capital PE | 2016-03-15 | $200m |
| Laboratorios Brovel S.A. de C.V. | Healthcare & Life Sciences | — | 2016-01-14 | $6.5m |
Compiled from an archive of 10,204 recorded transactions. This is a record of deals that were reported, not a complete history of what this company has bought, and nothing here is represented as being for sale.
Also buying
Comparable buyers
Other companies acquiring in healthcare & life sciences.
For owners
Own a healthcare & life sciences business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Are you an investor?
Register your mandate and we will send matching opportunities as they arise.
Register a mandateTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.